How much do you know about the incidence of extramedullary disease in patients with multiple myeloma? Take our latest quiz to test your knowledge.
How much do you know about the link between various germline mutations and ovarian cancer? Take our latest quiz to test your knowledge.
A recent study evaluated whether longstanding assumptions that thin nodular melanomas are less aggressive than thicker ones are accurate.
How much do you know about the use of PET/CT imaging to manage multiple myeloma? Take our latest quiz to test your knowledge.
The study authors evaluated the disease-free survival rate among patients with high-risk primary melanoma and the role of routine sentinel lymph node biopsy.
A new study reported that elderly patients experience a different extent of metastatic disease than do adults diagnosed at younger ages.
How knowledgeable are you about the use of proteasome inhibitors in relapsed/refractory multiple myeloma? Take our latest quiz to find out.
The updates to the guidelines reflect recent advances, including recommended immunotherapies and changes in tumor staging.
Cancer Network spoke with Dr. Shulin Li about his team’s research on the role of the FGL2 protein in glioblastoma immune evasion and tumor progression.
The updated version incorporates biologic factors to refine and improve the prognostic stratification of patients with breast cancer.